Amplify Weight Loss Drug & Treatment ETF (THNR): ETF
ETF traded on ARCX under symbol THNR. Quoted in usd.
Amplify Weight Loss Drug & Treatment ETF
+0.67%$25.91
ARCX:THNREquity
AUM $5.15M·YTD --·Yield --
- News
4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally
Zacks Investment Research3d ago
- News
Eli Lilly, Regeneron Lead Weight-Loss ETF THNR Higher
ETF Trends4d ago
- News
What the Holidays Hold for GLP-1 Stocks in THNR
ETF Trends5d ago
- News
Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss
Zacks Investment Research18d ago
- News
Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market
Zacks Investment Research18d ago
- News
From Laggard to Leader: The Surprising Comeback of Healthcare
ETF Trends26d ago
- News
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
Zacks Investment Research1mo ago
- News
Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in September
ETF Trends1mo ago
- News
NTHM's Index Rebalance Puts Thematic Rotation to Work
ETF Trends1mo ago
- News
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead
ETF Trends1mo ago